The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

February 16th, 2021|Categories: Alternative splicing, Clinical Development|

Scaglioni D, Catapano F, Ellis M, Torelli S, Chambers D, Feng L, Beck M, Sewry C, Monforte M, Harriman S, Koenig E, Malhotra J, Popplewell L, Guglieri M, Straub V, Mercuri E, Servais L, Phadke R, Morgan J, Muntoni Acta Neuropathol Commun. 2021 Jan 6;9(1):7. ...

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

December 23rd, 2020|Categories: Clinical Development, immunostimulation, Pre-Clinical Research, Toxicology|

Adams D, Polydefkis M, GonzĂ¡lez-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada LĂ³pez IA, Dispenzieri A, Quan D, ConceiĂ§Ă£o IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, PlantĂ©-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda ...

Go to Top